Cardiovascular Therapeutics : Impact Factor & More
eISSN: 1755-5922pISSN: 1755-5914
Open AccessShare this on:
Key Metrics
CiteScore 
4.6
H-Index
52
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.87
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cardiovascular Therapeutics
Cardiovascular Therapeutics Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | WILEY-HINDAWI |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2000 |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Cardiovascular Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cardiovascular Therapeutics
The Association Between Sedentary Behavior and Cardiovascular Disease Risk: An Analysis Based on NHANES Data
- 6 Apr 2026
- Cardiovascular Therapeutics
Ginsenoside Rb1 Mitigates Myocardial Fibrosis Through Inhibiting Exosomal\u2010Derived miRNA\u201021\u2013Associated Inflammation and Cardiac Signaling
- 26 Mar 2026
- Cardiovascular Therapeutics
Subclinical Hypothyroidism as a Risk for Coronary Artery Bypass Grafting
- 1 Jan 2026
- Cardiovascular Therapeutics
Hypermetabolism and Lipid Alterations Postburn: A Cardiovascular Perspective.
- 1 Jan 2026
- Cardiovascular therapeutics
Hotspots Evolution and Cutting-Edge Trends: A Bibliometric Analysis of Autophagy in Myocardial Infarction Studies From 2007 to 2025.
- 1 Jan 2026
- Cardiovascular therapeutics
Title not available
- 1 Jan 2026
- Cardiovascular Therapeutics
The Association Between Sedentary Behavior and Cardiovascular Disease Risk: An Analysis Based on NHANES Data
- 6 Apr 2026
- Cardiovascular Therapeutics
Ginsenoside Rb1 Mitigates Myocardial Fibrosis Through Inhibiting Exosomal\u2010Derived miRNA\u201021\u2013Associated Inflammation and Cardiac Signaling
- 26 Mar 2026
- Cardiovascular Therapeutics
Subclinical Hypothyroidism as a Risk for Coronary Artery Bypass Grafting
- 1 Jan 2026
- Cardiovascular Therapeutics
Hypermetabolism and Lipid Alterations Postburn: A Cardiovascular Perspective.
- 1 Jan 2026
- Cardiovascular therapeutics
Hotspots Evolution and Cutting-Edge Trends: A Bibliometric Analysis of Autophagy in Myocardial Infarction Studies From 2007 to 2025.
- 1 Jan 2026
- Cardiovascular therapeutics
Title not available
- 1 Jan 2026
- Cardiovascular Therapeutics
FAQs on Cardiovascular Therapeutics
How long has Cardiovascular Therapeutics been actively publishing? 
What is the publishing frequency of Cardiovascular Therapeutics?
How many articles did Cardiovascular Therapeutics publish last year?
What is the eISSN & pISSN for Cardiovascular Therapeutics?
What is Citescore for Cardiovascular Therapeutics?
What is the H Index for Cardiovascular Therapeutics ?
What is SNIP score for Cardiovascular Therapeutics?
What is the SJR for Cardiovascular Therapeutics?
Who is the publisher of Cardiovascular Therapeutics?
